PharmaShots | Incisive News in 3 Shots

Subscribe Now

Mutant Tumors

Jazz Pharmaceuticals Acquires Redx Pharma's Pre-clinical Pan-RAF Inhibitor Program for RAF and RAS Mutant Tumors

Jazz Pharmaceuticals Acquires Redx Pharma's Pre-clinical Pan-RAF Inhibitor Program for RAF and RAS Mutant Tumors

July 10, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us